— Know what they know.
Not Investment Advice

INAB NASDAQ

IN8bio, Inc.
1W: +14.2% 1M: +24.6% 3M: -4.9% YTD: -44.3% 1Y: -39.4% 3Y: -95.8% 5Y: -99.4%
$1.40
+0.00 (+0.00%)
 
Weekly Expected Move ±9.8%
$1 $1 $1 $2 $2
NASDAQ · Healthcare · Biotechnology · Tech Score Buy · Power 58 · $13.4M mcap · 7M float · 0.786% daily turnover · Short 27% of daily vol

Balance Sheet Trends

Total Assets
$32M +54.1% ▲
5Y CAGR: +9.1%
Total Liabilities
$5M -26.9% ▼
5Y CAGR: +12.8%
Shareholders Equity
$28M +90.3% ▲
5Y CAGR: +8.5%
Cash & Investments
$27M +143.6% ▲
5Y CAGR: +8.5%
Total Debt
$3M -44.7% ▼
5Y CAGR: +74.1%
Net Debt
-$24M -299.2% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$37M$18M$21M$11M$27M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$37M$18M$21M$11M$27M
Net Receivables$0$0$0$0$0
Inventory$0$0$0$0$0
Other Current Assets$52K$232K$270K$298K$788K
Total Current Assets$39M$22M$25M$13M$28M
Property, Plant & Equip.$3M$10M$9M$8M$4M
Goodwill & Intangibles$0$126K$0$0$0
Long-Term Investments$0$252K$256K$266K$220K
Other Non-Current Assets$409K$381K$255K$275K$146K
Total Non-Current Assets$3M$11M$9M$8M$4M
Total Assets$42M$33M$34M$21M$32M
— Liabilities —
Accounts Payable$395K$2M$924K$389K$309K
Short-Term Debt$0$0$0$2M$1M
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$926K$1M$2M$1M$2M
Total Current Liabilities$2M$6M$5M$3M$3M
Long-Term Debt$0$0$0$0$2M
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$2M$4M$3M$3M$2M
Total Liabilities$4M$10M$9M$6M$5M
— Equity —
Common Stock$2K$3K$4K$7K$10K
Retained Earnings-$33M-$61M-$91M-$122M-$141M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity$38M$23M$25M$14M$28M
Total Liabilities & Equity$42M$33M$34M$21M$32M
— Key Metrics —
Total Debt$2M$6M$5M$5M$3M
Net Debt-$35M-$12M-$16M-$6M-$24M
Total Investments$0$252K$256K$266K$220K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms